Artelo Biosciences Inc (ARTL)
1.32
0.00 (0.00%)
USD |
NASDAQ |
May 16, 16:00
1.32
0.00 (0.00%)
After-Hours: 20:00
Artelo Biosciences Total Liabilities (Quarterly): 1.291M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.291M |
| September 30, 2023 | 0.921M |
| June 30, 2023 | 0.609M |
| March 31, 2023 | 0.84M |
| December 31, 2022 | 1.021M |
| September 30, 2022 | 0.512M |
| June 30, 2022 | 0.567M |
| March 31, 2022 | 0.924M |
| December 31, 2021 | 1.084M |
| November 30, 2021 | 0.718M |
| August 31, 2021 | 0.593M |
| May 31, 2021 | 0.4239M |
| February 28, 2021 | 0.589M |
| November 30, 2020 | 0.4856M |
| August 31, 2020 | 0.501M |
| May 31, 2020 | 0.2685M |
| February 29, 2020 | 0.444M |
| November 30, 2019 | 0.5846M |
| August 31, 2019 | 1.022M |
| Date | Value |
|---|---|
| May 31, 2019 | 1.019M |
| February 28, 2019 | 1.176M |
| November 30, 2018 | 0.6405M |
| August 31, 2018 | 0.532M |
| May 31, 2018 | 0.4923M |
| February 28, 2018 | 0.1558M |
| November 30, 2017 | 0.1363M |
| August 31, 2017 | 0.0294M |
| May 31, 2017 | 0.3418M |
| February 28, 2017 | 0.0329M |
| November 30, 2016 | 0.01M |
| August 31, 2016 | 0.0174M |
| May 31, 2016 | 0.0131M |
| February 29, 2016 | 0.008M |
| November 30, 2015 | 0.0033M |
| August 31, 2015 | 0.0017M |
| May 31, 2015 | 0.00 |
| February 28, 2015 | 0.0015M |
| August 31, 2014 | 0.00 |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.2685M
Minimum
May 2020
1.291M
Maximum
Dec 2023
0.7208M
Average
0.601M
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 101.95B |
| NovaBay Pharmaceuticals Inc | 5.197M |
| Palatin Technologies Inc | 24.94M |
| iBio Inc | 24.82M |
| Theriva Biologics Inc | 14.61M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.04M |
| Shareholders Equity (Quarterly) | 11.75M |